Mollaret's meningitis is rare -only 32 cases were reported in 1982, the same year that the herpes virus was inculpated in a case report [6] . It is characterized by recurrent attacks of sudden onset meningitis that usually last for 2-7 days, with complete recovery but unpredictable recurrences. Alternative names are: benign recurrent aseptic meningitis; benign recurrent endothelial meningitis, and benign recurrent endothelial-leukocytic meningitis. In the first 24 h, large mononuclear cells with blunt pseudopods and bean-shaped, bilobed nucleitermed 'Mollaret's cells' -are typical in the CSF, but may be absent. Using electron microscopy, de Chadarévian and Becker [7] proved that Mollaret's endothelial cells were 'epitheloid-looking monocytes or macrophages'. Other examples of these cells have proved to be secondary to dermoid or epidermoid tumours [8] sited near the ventricles or spinal CSF; they may precipitate the leakage of tumour elements into the subarachnoid space and cause a recurrent chemical meningitis [9] . Recurrent Herpes simplex virus (HSV-2, less often HSV-1) meningitis is clinically indistinguishable from cases of idiopathic Mollaret's meningitis [10, 11] . In most herpetic
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The term 'Mollaret's meningitis' should, therefore, be restricted to idiopathic recurrent aseptic meningitis; whereas cases of recurrent meningitis known to be associated with HSV or, rarely, other viruses should be referred to as 'recurrent viral meningitis'. Acyclovir, valacyclovir, and famciclovir have been given to some patients but there is no controlled trial data to support their efficacy in preventing attacks.
Prof. Julien Bogousslavsky has perhaps the longest follow-up of a patient with Mollaret's meningitis. The patient started her episodes in 1945, at the age of 20, and was followed up by Raymond Adams in the 1970s. She had her last attack in 2006.
Pierre Mollaret (1898-1987)
Mollaret was a French physician of infectious diseases, who made important contributions to the management of malaria and poliomyelitis. He was born in Auxerre, France, on 10 July 1898. He started his medical studies in 1916, but was soon called to serve in World War I and was awarded the Croix de Guerre. Returning to Medicine, he graduated in 1926 and began a long association with his former teacher, Georges Charles Guillian In 1952, Dr. Pierre Lépine, of the Pasteur Institute, asked for Mollaret's help in dealing with an epidemic of poliomyelitis in Scandinavia. With Jacques Pocidalo, he prepared a centre to cater for cases with respiratory paralysis, using the new Engström respirators. Via tracheotomies they regulated ventilation and rapidly monitored and controlled plasma oxygen and carbon dioxide levels. This improved the outcome and survival of many polio patients in the French epidemic of 1954. He also developed an antigen for intradermal testing of cat-scratch disease (Bartonella henselae) .
Mollaret died in Montgeron, near Paris, in 1987.
